T1	PROC 261 269	tratados
#1	AnnotatorNotes T1	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T2	PROC 46 79	Estudio para evaluar la seguridad
T3	PROC 693 701	tratados
#2	AnnotatorNotes T3	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T4	CHEM 174 184	ribavirina
#3	AnnotatorNotes T4	C0035525; ribavirin; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T5	CHEM 186 189	RBV
#4	AnnotatorNotes T5	C0035525; ribavirin; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T6	DISO 206 254	infección crónica por el virus de la hepatitis C
#5	AnnotatorNotes T6	C4736230; chronic hepatitis C due to hepatitis C virus genotype 1a; Disease or Syndrome
T7	PROC 410 468	Estudio aleatorizado, doble ciego y controlado con placebo
T8	CHEM 559 566	ABT-333
#6	AnnotatorNotes T8	C3850285; ABT-333; Organic Chemical · Pharmacologic Substance
T9	PROC 474 508	evaluar la eficacia y la seguridad
#7	AnnotatorNotes T9	C0511730; Identify product efficacy and safety issues; Health Care Activity
T10	CHEM 591 601	ribavirina
#8	AnnotatorNotes T10	C0035525; ribavirin; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T11	CHEM 603 606	RBV
#9	AnnotatorNotes T11	C0035525; ribavirin; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T12	DISO 623 671	infección crónica por el virus de la hepatitis C
#10	AnnotatorNotes T12	C4736230; chronic hepatitis C due to hepatitis C virus genotype 1a; Disease or Syndrome
T13	CHEM 1136 1142	pegIFN
#11	AnnotatorNotes T13	C0907160; Pegylated Interferon Alfa; Immunologic Factor · Organic Chemical · Pharmacologic Substance
T14	DISO 962 971	estériles
#12	AnnotatorNotes T14	C0021359; Infertility; Pathologic Function | C0917730; Female sterility; Finding | C4074771; Sterility, Reproductive; Pathologic Function
T15	PROC 1007 1027	control de natalidad
#13	AnnotatorNotes T15	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T16	DISO 1032 1080	Infección crónica por el virus de la hepatitis C
#14	AnnotatorNotes T16	C4736230; chronic hepatitis C due to hepatitis C virus genotype 1a; Disease or Syndrome
T17	PROC 1113 1124	tratamiento
#15	AnnotatorNotes T17	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T18	CHEM 1145 1148	RBV
#16	AnnotatorNotes T18	C0035525; ribavirin; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T19	DISO 1167 1184	cirrosis hepática
#17	AnnotatorNotes T19	C0023890; Liver Cirrhosis; Disease or Syndrome
T20	PROC 1238 1267	screening de drogas y alcohol
#18	AnnotatorNotes T20	C1743165; Alcohol and/or drug screening; Diagnostic Procedure
T21	DISO 1270 1282	Sensibilidad
T22	CHEM 1306 1316	medicación
#19	AnnotatorNotes T22	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T23	CHEM 1329 1341	medicamentos
#20	AnnotatorNotes T23	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T24	PHYS 912 929	post-menopáusicas
#21	AnnotatorNotes T24	C0206159; Postmenopause; Organism Function
T25	CHEM 1411 1421	medicación
#22	AnnotatorNotes T25	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T26	DISO 673 676	VHC
#23	AnnotatorNotes T26	C0019196; Hepatitis C; Disease or Syndrome
T27	PROC 1436 1458	Pruebas de laboratorio
#24	AnnotatorNotes T27	C0022885; Laboratory Procedures; Laboratory Procedure
T28	PROC 1496 1549	análisis del antígeno de superficie de la hepatitis B
T29	CHEM 1509 1549	antígeno de superficie de la hepatitis B
#25	AnnotatorNotes T29	C0019168; Hepatitis B Surface Antigens; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T30	PROC 1555 1617	anticuerpos contra el virus de la inmunodeficiencia humana VIH
#26	AnnotatorNotes T30	C3714540; HIV Antibody Measurement; Laboratory Procedure
T31	DISO 256 259	VHC
#27	AnnotatorNotes T31	C0019196; Hepatitis C; Disease or Syndrome
T32	CHEM 512 518	ABT450
#28	AnnotatorNotes T32	C3712108; ABT-450; Organic Chemical · Pharmacologic Substance
T33	DISO 751 799	infección crónica por el virus de la hepatitis C
#29	AnnotatorNotes T33	C4736230; chronic hepatitis C due to hepatitis C virus genotype 1a; Disease or Syndrome
T34	DISO 1082 1085	VHC
#30	AnnotatorNotes T34	C0019196; Hepatitis C; Disease or Syndrome
T35	ANAT 1176 1184	hepática
#31	AnnotatorNotes T35	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T36	PROC 1390 1421	administración de la medicación
T37	CHEM 132 139	ABT-267
#32	AnnotatorNotes T37	C3713322; ABT-267; Organic Chemical · Pharmacologic Substance
T38	CHEM 124 130	ABT450
#33	AnnotatorNotes T38	C3712108; ABT-450; Organic Chemical · Pharmacologic Substance
T39	CHEM 142 149	ABT-333
#34	AnnotatorNotes T39	C3850285; ABT-333; Organic Chemical · Pharmacologic Substance
T40	CHEM 529 536	ABT-267
#35	AnnotatorNotes T40	C3713322; ABT-267; Organic Chemical · Pharmacologic Substance
T41	CHEM 519 528	ritonavir
#36	AnnotatorNotes T41	C0292818; ritonavir; Organic Chemical · Pharmacologic Substance
T42	CHEM 548 555	ABT-267
#37	AnnotatorNotes T42	C3713322; ABT-267; Organic Chemical · Pharmacologic Substance
T43	CHEM 538 545	ABT-450
#38	AnnotatorNotes T43	C3712108; ABT-450; Organic Chemical · Pharmacologic Substance
T44	Date 13 17	2012
T45	LIVB 194 201	adultos
#39	AnnotatorNotes T45	C0001675; Adult; Age Group
T46	Duration 216 223	crónica
#40	AnnotatorNotes T46	C0205191; chronic; Temporal Concept
T47	LIVB 231 254	virus de la hepatitis C
#41	AnnotatorNotes T47	C0220847; hepatitis C virus; Virus
T50	LIVB 611 618	adultos
#42	AnnotatorNotes T50	C0001675; Adult; Age Group
T51	Duration 633 640	crónica
#43	AnnotatorNotes T51	C0205191; chronic; Temporal Concept
T52	LIVB 648 671	virus de la hepatitis C
#44	AnnotatorNotes T52	C0220847; hepatitis C virus; Virus
T54	PROC 681 689	genotipo
#45	AnnotatorNotes T54	C1285573; Genotype determination; Laboratory Procedure
T55	Duration 761 768	crónica
#46	AnnotatorNotes T55	C0205191; chronic; Temporal Concept
T56	LIVB 776 799	virus de la hepatitis C
#47	AnnotatorNotes T56	C0220847; hepatitis C virus; Virus
T57	LIVB 838 845	mujeres
#48	AnnotatorNotes T57	C0043210; Woman; Population Group
T58	Age 846 861	de 18 a 70 años
T59	LIVB 894 901	mujeres
#49	AnnotatorNotes T59	C0043210; Woman; Population Group
T62	Duration 930 943	más de 2 años
T63	Duration 1042 1049	crónica
#50	AnnotatorNotes T63	C0205191; chronic; Temporal Concept
T64	LIVB 1057 1080	virus de la hepatitis C
#51	AnnotatorNotes T64	C0220847; hepatitis C virus; Virus
T66	PROC 1088 1096	genotipo
#52	AnnotatorNotes T66	C1285573; Genotype determination; Laboratory Procedure
T67	Neg_cue 1151 1153	No
T69	Duration 1361 1376	las dos semanas
T70	LIVB 1577 1613	virus de la inmunodeficiencia humana
#53	AnnotatorNotes T70	C0019682; HIV; Virus
T71	LIVB 1614 1617	VIH
#54	AnnotatorNotes T71	C0019682; HIV; Virus
T48	LIVB 828 835	Varones
#55	AnnotatorNotes T48	C0025266; Male population group; Population Group
T49	CHEM 1251 1257	drogas
#56	AnnotatorNotes T49	C0086190; Illicit Drugs; Hazardous or Poisonous Substance
T53	CHEM 97 123	productos en investigación
#57	AnnotatorNotes T53	C0013230; Investigational New Drugs; Pharmacologic Substance
T60	PROC 946 971	quirúrgicamente estériles
#58	AnnotatorNotes T60	C0015787; Female Sterilization; Therapeutic or Preventive Procedure (?)
A1	Population_data T45 Age
A2	Population_data T50 Age
A3	Assertion T19 Negated
A4	Status T3 History_of
A5	Status T60 History_of
A6	Status T17 History_of
A7	Status T13 History_of
A8	Status T18 History_of
A9	Status T21 History_of
A10	Assertion T23 Contraindicated
A11	Status T1 History_of
#59	AnnotatorNotes T2	C1705187; Safety Study; Research Activity
#60	AnnotatorNotes T7	C0013072; Double-Blind Method; Research Activity + C0599724; placebo controlled study; Research Activity · Intellectual Product  + C0206034; Clinical Trials, Randomized; Research Activity
#61	AnnotatorNotes T21	C0020517; Hypersensitivity; Pathologic Function
#62	AnnotatorNotes T36	C3469597; Administration of medication; Therapeutic or Preventive Procedure
T61	Neg_cue 312 314	no
T65	Quantifier_or_Qualifier 324 333	aprobados
A12	Assertion T65 Negated
#63	AnnotatorNotes T65	C0205540; Approved; Qualitative Concept
T68	Food 1260 1267	alcohol
#64	AnnotatorNotes T68	C0001967; Alcoholic Beverages; Food
T72	Observation 85 91	efecto
#65	AnnotatorNotes T72	C1518681; Outcome of Therapy; Finding (?)
R1	Causes Arg1:T53 Arg2:T72	
R2	Causes Arg1:T38 Arg2:T72	
R3	Causes Arg1:T37 Arg2:T72	
R4	Causes Arg1:T39 Arg2:T72	
R5	Experiences Arg1:T45 Arg2:T72	
R6	Experiences Arg1:T45 Arg2:T38	
R7	Experiences Arg1:T45 Arg2:T53	
R8	Has_Duration_or_Interval Arg1:T6 Arg2:T46	
R9	Causes Arg1:T47 Arg2:T6	
R10	Causes Arg1:T47 Arg2:T31	
R11	Experiences Arg1:T45 Arg2:T1	
R12	Negation Arg1:T61 Arg2:T65	
R13	Combined_with Arg1:T32 Arg2:T41	
R14	Combined_with Arg1:T41 Arg2:T40	
R15	Combined_with Arg1:T38 Arg2:T37	
R16	Combined_with Arg1:T37 Arg2:T39	
R17	Combined_with Arg1:T39 Arg2:T4	
R18	Combined_with Arg1:T39 Arg2:T5	
R19	Combined_with Arg1:T43 Arg2:T42	
R20	Combined_with Arg1:T40 Arg2:T8	
R21	Combined_with Arg1:T42 Arg2:T8	
R22	Combined_with Arg1:T8 Arg2:T10	
R23	Combined_with Arg1:T8 Arg2:T11	
R24	Experiences Arg1:T50 Arg2:T32	
R25	Before Arg1:T1 Arg2:T53	
T73	Quantifier_or_Qualifier 681 691	genotipo 1
R26	Has_Quantifier_or_Qualifier Arg1:T52 Arg2:T73	
R27	Before Arg1:T1 Arg2:T38	
R28	Before Arg1:T1 Arg2:T37	
R29	Before Arg1:T1 Arg2:T39	
R30	Before Arg1:T1 Arg2:T4	
R31	Before Arg1:T1 Arg2:T5	
R32	Before Arg1:T3 Arg2:T32	
R33	Before Arg1:T3 Arg2:T41	
R34	Before Arg1:T3 Arg2:T40	
R35	Before Arg1:T3 Arg2:T43	
R36	Before Arg1:T3 Arg2:T42	
R37	Before Arg1:T3 Arg2:T8	
R38	Before Arg1:T3 Arg2:T10	
R39	Before Arg1:T3 Arg2:T11	
R40	Experiences Arg1:T50 Arg2:T43	
R41	Experiences Arg1:T50 Arg2:T12	
R42	Experiences Arg1:T45 Arg2:T6	
R43	Experiences Arg1:T45 Arg2:T31	
R44	Experiences Arg1:T50 Arg2:T26	
R45	Causes Arg1:T52 Arg2:T12	
R46	Causes Arg1:T52 Arg2:T26	
R47	Has_Duration_or_Interval Arg1:T12 Arg2:T51	
R48	Experiences Arg1:T50 Arg2:T54	
R49	Causes Arg1:T56 Arg2:T33	
R50	Has_Duration_or_Interval Arg1:T33 Arg2:T55	
R51	Has_Age Arg1:T57 Arg2:T58	
R52	Has_Age Arg1:T48 Arg2:T58	
R53	Experiences Arg1:T59 Arg2:T24	
R54	Has_Duration_or_Interval Arg1:T24 Arg2:T62	
R55	Experiences Arg1:T59 Arg2:T60	
R56	Experiences Arg1:T59 Arg2:T14	
R57	Experiences Arg1:T59 Arg2:T15	
T74	Quantifier_or_Qualifier 1088 1098	genotipo 1
R58	Has_Quantifier_or_Qualifier Arg1:T64 Arg2:T74	
R59	Causes Arg1:T64 Arg2:T34	
R60	Causes Arg1:T64 Arg2:T16	
R61	Has_Duration_or_Interval Arg1:T16 Arg2:T63	
T75	Observation 1101 1124	Fracaso del tratamiento
#66	AnnotatorNotes T75	C0162643; treatment failure; Finding
R62	Before Arg1:T17 Arg2:T75	
R63	Used_for Arg1:T13 Arg2:T17	
R64	Used_for Arg1:T18 Arg2:T17	
R65	Location_of Arg1:T35 Arg2:T19	
R66	Negation Arg1:T67 Arg2:T19	
T76	Result_or_Value 1213 1231	Resultado positivo
#67	AnnotatorNotes T76	C1446409; Positive; Finding
R67	Has_Result_or_Value Arg1:T20 Arg2:T76	
R68	Causes Arg1:T22 Arg2:T21	
R69	Overlap Arg1:T23 Arg2:T69	
R70	Before Arg1:T23 Arg2:T36	
R71	Used_for Arg1:T25 Arg2:T36	
T77	Result_or_Value 1471 1489	Resultado positivo
#68	AnnotatorNotes T77	C1446409; Positive; Finding
R72	Has_Result_or_Value Arg1:T28 Arg2:T77	
R73	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T77	
R74	Causes Arg1:T4 Arg2:T72	
R75	Causes Arg1:T5 Arg2:T72	
R76	Has_Duration_or_Interval Arg1:T26 Arg2:T51	
R79	Causes Arg1:T49 Arg2:T76	
R80	Causes Arg1:T68 Arg2:T76	
T78	Observation 1436 1468	Pruebas de laboratorio anormales
#69	AnnotatorNotes T78	C3648370; laboratory tests nonspecific abnormal findings; Finding
R77	Causes Arg1:T70 Arg2:T77	
R78	Causes Arg1:T71 Arg2:T77	
R81	Causes Arg1:T29 Arg2:T77	
R82	Experiences Arg1:T50 Arg2:T3	
#70	AnnotatorNotes T28	C0201477; Hepatitis B surface antigen measurement; Laboratory Procedure
A13	Experiencer T45 Patient
A14	Experiencer T50 Patient
A15	Experiencer T57 Patient
A16	Experiencer T48 Patient
A17	Experiencer T59 Patient
